OpenVSafe by OpenVAERS
Search V-safe

75Y-31306-25159

2 vaccinations 10 coded responses 17 check-ins 10 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
021 / MA
Registered
2021-04-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-18
    Registered in v-safe
  3. 2021-04-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  4. 2021-04-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Generalized itchiness of skin in many areas of body
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pruritus — Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Free text: Generalized itching on many parts of the body
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-26
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-05-08
    Dose 2 — Pfizer-BioNTech
  8. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-05-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Oropharyngeal pain — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sore throat, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-15
    Survey response — day 7, dose 2
    MedDRA: Chest pain, Cough, Discomfort, Myalgia, Oropharyngeal pain, Respiratory symptom, Rhinorrhoea — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Upper respiratory symptoms. Runny nose, dry cough, sore throat. Muscle pain in chest. Uncomfortable to breathe.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-22
    Survey response — day 14, dose 2
    MedDRA: Chest discomfort, Cough, Dizziness, Fatigue, Headache, Immunodeficiency, Influenza like illness, Nausea, Oropharyngeal pain, Pain, Sneezing — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Ongoing flu-like symptoms since receiving vaccine 15 days ago. Coughing, sneezing, sore throat, uncomfortable to take a full, deep breath, widespread body pain. SEVERE fatigue. Intermittent nausea, dizziness and headaches DAILY. Immunocompromised
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-29
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  15. 2021-06-05
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-06-12
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-06-19
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-08-07
    Survey response — 3 months, dose 2
    MedDRA: Bronchial hyperreactivity, Dizziness, Dyspnoea, Fatigue, Mobility decreased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Shortness of breath both with and without exertion, reactive airway requiring new medication (albuterol inhaler). Possible asthma diagnosis. Excessive fatigue, dizziness, trouble getting out of bed daily.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  19. 2021-08-07
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-11-06
    Survey response — 6 months, dose 2
    MedDRA: Bronchial hyperreactivity, Chest pain, Dyspnoea, Fatigue, Loss of personal independence in daily activities — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Reactive Airway Disease newly emerged since receipt of Covid vaccine. Requires upcoming visit to pulmonary specialist. Daily difficulty breathing , chest pain, severe fatigue. Many daily activities negatively impacted by this new condition.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-11-06
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  22. 2021-11-09
  23. 2022-05-09
    Survey response — 12 months, dose 2
    MedDRA: Cataract, Chest pain, Dyspnoea, Obstructive sleep apnoea syndrome, Visual acuity reduced — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Rapid onset and Worsening visual acuity and cataracts, moderate obstructive sleep apnea, chest pain, shortness of breath.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech
22021-05-08Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-19

Systemic reaction (other): Generalized itchiness of skin in many areas of body

2021-04-20

Systemic reaction (other): Generalized itching on many parts of the body

Release 8 — days 1–6 daily, dose 2

2021-05-11

Systemic reaction (other): Dizziness

2021-05-12

Systemic reaction (other): Dizziness

2021-05-13

Systemic reaction (other): Sore throat, dizziness

Release 8 — day 7, dose 2

2021-05-15

Systemic reaction (other): Upper respiratory symptoms. Runny nose, dry cough, sore throat. Muscle pain in chest. Uncomfortable to breathe.

Release 8 — day 14, dose 2

2021-05-22

Symptoms: Ongoing flu-like symptoms since receiving vaccine 15 days ago. Coughing, sneezing, sore throat, uncomfortable to take a full, deep breath, widespread body pain. SEVERE fatigue. Intermittent nausea, dizziness and headaches DAILY. Immunocompromised cut off by CDC

Release 9 — 3 months, dose 2

2021-08-07

Symptoms: Shortness of breath both with and without exertion, reactive airway requiring new medication (albuterol inhaler). Possible asthma diagnosis. Excessive fatigue, dizziness, trouble getting out of bed daily.

Release 10 — 6 months, dose 2

2021-11-06

Symptoms: Reactive Airway Disease newly emerged since receipt of Covid vaccine. Requires upcoming visit to pulmonary specialist. Daily difficulty breathing , chest pain, severe fatigue. Many daily activities negatively impacted by this new condition.

Release 11 — 12 months, dose 2

2022-05-09

Symptoms: Rapid onset and Worsening visual acuity and cataracts, moderate obstructive sleep apnea, chest pain, shortness of breath.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchial hyperreactivity ✓ · ✓
SDCataract · · ✓
SDChest discomfort ✓ ✓ ✓
SDChest pain · · ✓
SDCough ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDImmunodeficiency ✓ ✓ ✓
SDInfluenza like illness ✓ ✓ ✓
SDLoss of personal independence in daily activities · · ✓
SDMobility decreased ✓ · ✓
SDNausea ✓ ✓ ✓
SDObstructive sleep apnoea syndrome · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDSneezing ✓ ✓ ✓
SDVisual acuity reduced · · ✓
SROChest pain ✓ ✓ ✓
SROCough ✓ ✓ ✓
SRODiscomfort ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROMyalgia ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SRORespiratory symptom ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release